About: RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.19 (-4.80%)
RNXT NASDAQ RenovoRx Inc
RenovoRx Inc share price
RNXT price activity
Last Price
$1.250
Change (24hr)
-0.03 USD (-2.34%)
Volume
253.04K
Volume (4w avg)
-
Open
$1.26
Day Range
$1.25 - $1.26
Previous Close
$1.28
Last Trade
12 Oct, 8:03 pm GMT+0
Delayed
12 Oct, 8:03 pm GMT+0
RNXT price performance
Delayed
12 Oct, 8:03 pm GMT+0
RNXT Market Signals